Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: A systematic review of the literature

BMJ Open

Volumn 5, Issue 6, 2015, Pages

  Plazy, Mélanie ^a   Orne Gliemann, Joanna ^a   Dabis, François ^a   Dray Spira, Rosemary ^b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE;

AFRICA SOUTH OF THE SAHARA; BODY MASS; CD4 LYMPHOCYTE COUNT; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; PATIENT CARE; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS; FEMALE; HIV INFECTIONS; MALE; ORGANIZATION AND MANAGEMENT; PATIENT DROPOUT; PATIENT SELECTION;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; ELIGIBILITY DETERMINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT DROPOUTS; PATIENT SELECTION;

EID: 84937231362     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006927     Document Type: Review

References (36)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic. 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en.pdf (accessed 7 Jul 2014).
2. Kranzer K, Govindasamy D, Ford N., et al. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2012; 15:17383.
3. Mugglin C, Estill J, Wandeler G., et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 2012; 17:1509-20.
4. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8:e1001056.
5. Feldacker C, Johnson D, Hosseinipour M., et al. Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi. PLoS ONE 2012; 7: e50871.
6. Plazy M, Dray-Spira R, Orne-Gliemann J, et al. Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa. Trop Med Int Health 2014; 19:680-9.
7. Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22:1897-908.
8. Boyles T, Wilkinson L. How should we care for patients who are not yet eligible for ART? South Afr J HIV Med 2011; 12:11-13.
9. WHO, UNICEF, UNAIDS. Global update on HIV treatment 2013: Results, impact and opportunities. 2013. http://www.who.int/hiv/pub/progressreports/update2013/en/index.html (accessed 7 Jul 2014).
10. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf (accessed 7 Jul 2014).
11. WHO. Service delivery approaches to HIV testing and counselling (HTC): a strategic HTC programme framework. 2012. http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877-eng.pdf (accessed 7 Jul 2014).
12. Bastard M, Nicolay N, Szumilin E., et al. Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors. J Acquir Immune Defic Syndr 2013; 64:455-63.
13. Clouse K, Pettifor A, Shearer K., et al. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Health 2013; 18:451-60.
14. Clouse K, Pettifor AE, Maskew M, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2013; 62:e39-46.
15. Hassan AS, Fielding KL, Thuo N.M., et al. Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study. Trop Med Int Health 2012; 17:82-93.
16. Honge BL, Jespersen S, Nordentoft P.B., et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open 2013; 3:e003499.
17. Kohler PK, Chung MH, McGrath C.J., et al. Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya. AIDS 2011; 25:1657-61.
18. Kranzer K, Zeinecker J, Ginsberg P., et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE 2010; 5:e13801.
19. Lessells RJ, Mutevedzi PC, Cooke G.S., et al. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 2011; 56: e79-86.
20. Namusobya J, Semitala FC, Amanyire G, et al. High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/muL under routine program conditions in Uganda. Clin Infect Dis 2013; 57:1343-50.
21. Pati R, Lahuerta M, Elul B., et al. Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique. J Int AIDS Soc 2013; 16:18490.
22. Nwuba C, Livinus I, Okoye M., et al. Retention of pre-ART clients in care: impact of stage specific interventions. 7th IAS conference on HIV pathogenesis, treatment and prevention; 30 June-3 July 2013; Kuala Lumpur, Malaysia, 2013.
23. Sialubanje C, Miyano S, Chipeta V., et al. Successfully enrolled in HIV care but not linked to timely treatment: poor retention and monitoring of pre-ART patients who are not yet eligible for antiretroviral therapy. 16th International Conference on AIDS & STIs in Africa; 4-8 December 2011; Addis Ababa, Ethiopia, 2011.
24. Wettstein C, Mugglin C, Egger M., et al. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS 2012; 26:2361-73.
25. Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS 2014; 28:589-98.
26. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS 2012; 26:2059-67.
27. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en.pdf (accessed 7 Jul 2014).
28. Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004; 38:1454-63.
29. Horvath T, Azman H, Kennedy G.E., et al. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev 2012; 3: CD009756.
30. Barnighausen T, Chaiyachati K, Chimbindi N., et al. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 11:942-51.
31. Wynberg E, Cooke G, Shroufi A., et al. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc 2014; 17:18809.
32. Mwai GW, Mburu G, Torpey K., et al. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2013; 16:18586.
33. Larson BA, Schnippel K, Brennan A., et al. Same-day CD4 testing to improve uptake of HIV care and treatment in South Africa: point-of-care is not enough. AIDS Res Treat 2013; 2013:941493.
34. Iwuji CC, Orne-Gliemann J, Tanser F., et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials 2013; 14:230.
35. Hayes R, Ayles H, Beyers N., et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment-a study protocol for a cluster randomised trial. Trials 2014; 15:57.
36. Iwuji C, Orne-Gliemann J, Tanser F., et al. Feasibility and acceptability of an antiretroviral treatment as prevention (TasP) intervention in rural South Africa: results from the ANRS 12249 TasP cluster-randomised trial. 20th International AIDS Conference; Melbourne; 20-25 July 2014. Abstract WEAC0105LB.